Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-15 4:40 pm Sale | 2026-06-11 | 13D | BEONE MEDICINES LTD. AMERICAN ONC | BAKER BROS. ADVISORS LP | 115,912,814 8.000% | -5,499 (-0.00%) | Filing History |
| 2026-05-26 5:04 pm Purchase | 2026-05-21 | 13D | KINIKSA PHARMACEUTICALS INTL P KNSA | BAKER BROS. ADVISORS LP | 3,253,341 7.000% | 102,312 (+3.25%) | Filing History |
| 2026-05-15 4:18 pm Purchase | 2026-03-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BAKER BROS. ADVISORS LP | 8,876,346 9.990% | 4,530,610 (+104.25%) | Filing History |
| 2026-05-15 4:17 pm Purchase | 2026-03-31 | 13G | GRAIL INC GRAL | BAKER BROS. ADVISORS LP | 4,028,614 9.800% | 1,943,281 (+93.19%) | Filing History |
| 2026-05-15 4:17 pm Sale | 2026-03-31 | 13G | KALA BIO, INC PAR $ KALA | BAKER BROS. ADVISORS LP | 2,312 0.010% | -2,887,743 (-99.92%) | Filing History |
| 2026-05-15 4:17 pm Purchase | 2026-03-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | BAKER BROS. ADVISORS LP | 1,753,198 6.300% | 1,753,198 (New Position) | Filing History |
| 2026-05-11 4:59 pm Purchase | 2026-05-07 | 13D | INCYTE CORPORATION INCY | BAKER BROS. ADVISORS LP | 31,225,572 15.600% | 12,155 (+0.04%) | Filing History |
| 2026-05-07 4:10 pm Purchase | 2026-04-30 | 13G | ABCELLERA BIOLOGICS INC. ABCL | BAKER BROS. ADVISORS LP | 33,012,138 10.800% | 5,486,498 (+19.93%) | Filing History |
| 2026-04-22 4:22 pm Purchase | 2026-04-20 | 13D | PRELUDE THERAPEUTICS INC PRLD | BAKER BROS. ADVISORS LP | 10,295,301 15.500% | 25,333 (+0.25%) | Filing History |
| 2026-04-16 4:32 pm Sale | 2026-04-16 | 13D | BEONE MEDICINES LTD. AMERICAN ONC | BAKER BROS. ADVISORS LP | 115,918,313 8.000% | -9,358,297 (-7.47%) | Filing History |
| 2026-03-24 4:06 pm Purchase | 2026-03-20 | 13D | CELCUITY INC CELC | BAKER BROS. ADVISORS LP | 9,582,874 19.990% | 1,837,182 (+23.72%) | Filing History |
| 2026-02-26 6:59 pm Purchase | 2026-02-24 | 13D | ACADIA PHARMACEUTICALS INC ACAD | BAKER BROS. ADVISORS LP | 43,294,373 25.400% | 66,774 (+0.15%) | Filing History |
| 2026-02-17 4:26 pm Purchase | 2025-12-31 | 13G | GRAIL INC GRAL | BAKER BROS. ADVISORS LP | 2,085,333 5.300% | 2,085,333 (New Position) | Filing History |
| 2026-02-17 4:25 pm Purchase | 2025-12-31 | 13G | ALKERMES PLC ALKS | BAKER BROS. ADVISORS LP | 10,012,267 6.100% | 10,012,267 (New Position) | Filing History |
| 2026-02-17 4:20 pm Purchase | 2025-12-31 | 13G | KALA BIO, INC. KALA | BAKER BROS. ADVISORS LP | 57,801 9.990% | 42,906 (+288.06%) | Filing History |
| 2026-02-17 4:19 pm Purchase | 2025-12-31 | 13G | REVOLUTION MEDICINES INC RVMD | BAKER BROS. ADVISORS LP | 9,455,357 4.900% | 90,385 (+0.97%) | Filing History |
| 2026-02-17 4:16 pm Purchase | 2025-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | BAKER BROS. ADVISORS LP | 7,527,996 7.200% | 776,431 (+11.50%) | Filing History |
| 2026-02-17 4:13 pm Sale | 2025-12-31 | 13G | STOKE THERAPEUTICS INC STOK | BAKER BROS. ADVISORS LP | 3,336,697 5.800% | -1,031,746 (-23.62%) | Filing History |
| 2026-02-17 4:10 pm Sale | 2025-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BAKER BROS. ADVISORS LP | 4,345,736 6.700% | -570,359 (-11.60%) | Filing History |
| 2026-02-10 6:31 pm Purchase | 2026-02-06 | 13D | INCYTE CORPORATION INCY | BAKER BROS. ADVISORS LP | 31,213,417 15.700% | 3,521 (+0.01%) | Filing History |